State · THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND) — $38.3M (CHE)
Key claim: The U.S. Department of State obligated $38.3 million to the Global Fund to Fight AIDS, Tuberculosis and Malaria to purchase lenacapavir for PrEP through Wambo.org for DOS/GHSD-financed beneficiaries in PEPFAR-supported countries.
Abstract
Department of State obligated $38.3M to THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND), for work in CHE. TO FUND THE PURCHASE OF LENACAPAVIR FOR PREP THROUGH WAMBO.ORG FOR DOS / GHSD-FINANCED BENEFICIARIES IN PEPFAR-SUPPORTED COUNTRIES.
Why this matters
This obligation shows the State Department using the Global Fund’s Wambo.org procurement platform to acquire a novel long-acting HIV prevention drug (lenacapavir) for PEPFAR beneficiaries, blending bilateral PEPFAR financing with multilateral procurement infrastructure. It marks an early US commitment to scaling long-acting PrEP across PEPFAR countries and is a distinct funding channel from the direct bilateral awards that dominate this area.